Synthesis and in vitro evaluation of [18F](R)-FEPAQ: a potential PET ligand for VEGFR2.
Prabhakaran, Jaya; Arango, Victoria; Majo, Vattoly J; Simpson, Norman R; Kassir, Suham A; Underwood, Mark D; Polavarapu, Hanish; Bruce, Jeffrey N; Canoll, Peter; Mann, J John; Kumar, J S Dileep.
Bioorg Med Chem Lett
; 22(15): 5104-7, 2012 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-22749281
VEGF- and VEGFR2-Targeted Liposomes for Cisplatin Delivery to Glioma Cells.
Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2.
Investigation of a novel molecular descriptor for the lead optimization of 4-aminoquinazolines as vascular endothelial growth factor receptor-2 inhibitors: application for quantitative structure-activity relationship analysis in lead optimization.
Biphenyl derivatives incorporating urea unit as novel VEGFR-2 inhibitors: design, synthesis and biological evaluation.
VEGFR2 expression and TGF-ß signaling in initial and recurrent high-grade human glioma.
Recent advances in structure-based drug design and virtual screening of VEGFR tyrosine kinase inhibitors.
Internalization of Vectorized Liposomes Loaded with Plasmid DNA in C6 Glioma Cells.
Pulsed Dendritic Cells for the Therapy of Experimental Glioma.
Functional binding surface of a ß-hairpin VEGF receptor targeting peptide determined by NMR spectroscopy in living cells.
Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold.